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Summary An eight year old English boy presented with an abdominal undifferentiated 'Burkitt-like'
lymphoma. Lymphoma cells from ascitic fluid were cultured on a human embryo fibroblast feeder layer and,
after a short lag period, a cell line (DH-BL) was established which, like the original tumour, was both
negative for the Epstein-Barr nuclear antigen (EBNA) and expressed a monoclonal pattern of surface
immunoglobulin (a1). DH-BL also possessed the Burkitt-related 8:14 chromosome translocation in all
metaphases analysed; no other chromosomal abnormalities were present. The cell surface phenotype of the
original biopsy cells and the cultured tumour cells in early passage were investigated using a panel of
monoclonal antibodies to B lineage-associated antigens. These antibodies had recently been used to
characterise African 'endemic' Burkitt's lymphoma (BL) biopsy cells and their derived cell lines. The cell
surface phenotype of this English EBNA negative Burkitt-like lymphoma biopsy was indistinguishable from
that previously shown by biopsies of EBNA positive endemic BLs. It therefore appears that both the endemic
and sporadic forms of BL, as illustrated by this case, may be derived from the same subset ofprogenitor cells.
When Burkitt's lymphoma (BL) was first described
it was believed to be confined to certain parts of
equatorial Africa and New Guinea coincident with
holoendemic malarial infection. However, sporadic
cases of the disease indistinguishable from BL on
histological grounds began to be reported from
countries outside these endemic areas (Burkitt,
1967). In addition to the histological similarities,
both endemic and sporadic cases of BL display the
same characteristic chromosomal translocation
involving the long arm of chromosome 8 and a
region of chromosome 14 or 2 or 22 near the
relevant immunoglobulin gene locus (Lenoir et al.,
1982). However, there are significant differences
between the two geographically separate forms of
the disease. Firstly, they show different anatomical
distributions. Endemic BL tends to involve the jaw
and gonads whereas sporadic BL tends to involve
the gastrointestinal tract, bone marrow or per-
ipheral lymph nodes (Wright & Isaacson, 1983).
Secondly, the Epstein-Barr (EB) virus is present in
the malignant cells in at least 96% of endemic BL
cases but in only a minority (15-20%) of sporadic
BL cases (Ziegler et al., 1976).
Debate continues as to whether BL should be
considered as a single clinical entity, or should be
classified into separate endemic and sporadic forms,
or alternatively, into separate EB virus genome-
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positve and -negative forms (zur Hausen, 1975; de
The et al., 1978). In this context Rowe et al. (1985)
have compared a number of EB virus-positive BL
lines from both endemic and sporadic tumours for
cell surface phenotype as defined by the cells'
reactivity with a panel of monoclonal antibodies
against B cell associated antigens. Cell lines derived
from the two forms of virus-associated BL showed
different ranges of phenotype and different growth
patterns even within the first few in vitro passages.
This suggested that the two forms of the tumour
may be derived from distinct subsets of B cells in
vivo, but the question could not be unequivocally
resolved in the absence of data on fresh biopsy
cells.
It was clearly important to extend this type of
approach, analysing both tumour biopsy cells and
the derived cell line, to cases of sporadic BL which
were negative for the EB virus genome. The recent
diagnosis of an EB virus-negative Burkitt-like
lymphoma presenting in an English child provided
the opportunity to characterise both the biopsy
cells and the subsequent cell line from this tumour
with the same panel of monoclonal antibody
markers as used in the earlier work.
Materials and methods
Clinical history
The patient, DH, was an English male aged 8
years. Two weeks before admission he developed
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spasms of backache and ten days before admission
complained of intermittent abdominal and limb
pains. There was no significant past history or
family history.
On examination he was found to have a palpable
suprapubic mass 11 cm x 9cm, arising from the
pelvis. There was no palpable lymphadenopathy or
hepatosplenomegaly. Ultrasound confirmed that the
mass was solid in nature and showed dilated
collecting systems of both kidneys, indicating mild
ureteric obstruction. An exploratory laparotomy
and biopsy were undertaken and imprints of the
tumour showed lymphoblasts of characteristic L3
morphology (Bennett et al., 1976). Bone marrow
aspirate, trephine biopsy and lumbar puncture for
cerebral spinal fluid cytology, showed no evidence
of disease elsewhere.
The patient was treated according to a
modification of the UKCCSG NHL protocol (Mott
et al., 1984). There was dramatic regression of the
disease within hours of initiation of the treatment.
Since that time, a period of 27 months, he has
remained well with no evidence of recurrent disease.
The following specimens were obtained from the
patient before therapy was commenced: heparinized
peripheral blood (10Uml-1) and ascites fluid
collected in sterile tissue culture medium. The
patient's plasma was found to be negative for IgG
antibodies to EB VCA when tested by direct
immunofluorescence (Henle & Henle, 1966).
Cell culture
All cultures were carried out in RPMI 1640
medium supplemented with 2mM glutamine,
pencillin (100IUml -1), streptomycin (100pgml-1)
and 10% v/v foetal calf serum (FCS) (Sera Lab.,
Crawley Down, Sussex, UK).
(a) Establishment of lymphoma-derived cell line
(DH-BL) Viable mononuclear cells were isolated
from the ascites sample by centrifugation over
Ficoll-Hypaque by standard techniques. Aliquots of
tumour cells were immediately cryopreserved in
liquid nitrogen. Fresh tumour cells were cultured
on human embryo fibroblasts in 2ml Linbro plates
at 106 tumour cells per well as described fully
elsewhere (Rooney et al., 1986). The cultures were
fed by replacing half the medium twice weekly.
When growth commenced, the cells were initially
subcultured onto fresh feeder cells and then into
plastic tissue culture flasks.
(b) Establishment of lymphoblastoid cell line (DH-
LCL) Mononuclear cells were separated from the
whole blood by the method of Boyum (1968).
Normal B cells within this population were infected
with the B95-8 strain of EB virus exactly as in
earlier work (Moss et al., 1978; Finerty et al., 1982)
to give an EB virus-transformed B-lymphoblastoid
cell line (LCL) of non-malignant origin. The LCL
was maintained by replacing half the medium twice
weekly.
Immunofluorescence tests
1. EB nuclear antigen (EBNA) Cell smears were
fixed in methanol:acetone (1:2) for 5min at -20°C
and stored at -20°C until required. The slides were
stained for EBNA as described elsewhere (Crawford
et al., 1978).
2. Surface and cytoplasmic immunoglobulin Cells
were analysed for surface and cytoplasmic immuno-
globulin by standard direct immunofluorescence as
previously described (Finerty et al., 1982). Biopsy
cells were also analysed for surface immunoglobulin
by the method of Gregory et al. (1985).
3. Surface phenotyping using monoclonal anti-
bodies The expression of various antigens at the
cell surface was examined by indirect
immunofluorescence using a panel of monoclonal
antibodies referred to in Table I. Monoclonal
antibodies MHM6, AC2, Ki-1, Ki-24 and 38.13
were used at dilutions of 1:100 to 1:500 of ascitic
fluid preparations. The antibodies Bl, J5 and
OKT11 were obtained commercially and used as
recommended by the suppliers. The FITC-
conjugated second-step polyclonal antisera em-
ployed were a 1:100 dilution of goat anti-mouse
IgG (Sigma, London) or, for the 38.13 rat
monoclonal antibody, a 1:20 dilution of goat anti-
rat IgM (Nordic Immunological Laboratories Ltd.,
Maidenhead), using as the diluent phosphate
buffered saline (PBS) containing 10% EB virus
antibody negative normal human serum and 10%
normal goat serum.
The surface phenotyping was carried out as
previously described: (a) on biopsy cells as
described by Gregory et al., (1985) and (b) on early
in vitro passages of the cell lines under test as
described by Rowe et al. (1985).
Chromosomal analysis
Chromosome spreads were prepared and G-banded
following the method of Autio and Schroder
(1982). Briefly, desiccated chromosome slides were
incubated at 60°C in 2 x SSC overnight, treated
with 0.1% trypsin (Gibco Ltd., Paisley, Scotland) in
PBS for 20sec and stained in 2% giemsa (Gurr,
BDH Chemicals Ltd., Poole, UK). Karyotypes
were determined by the analysis of 20 metaphase
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Table I Monoclonal antibodies used for cell surface phenotyping.
Monoclonal antibody Specificity Source Reference
Pan-B cell-associated antigen
(35,000mol.wt)
cALLA (100,000mol. wt)
BL cell-associated antigen
(glycolipid)
Sternberg-Reed cell-associated
antigen
B-lymphoblastoid cell-associated
antigen (45,000mol.wt)
Lymphoblastoid cell-associated
antigen (80,000mol. wt)
Sternberg-Reed cell-associated
antigen (110,000mol. wt)
Pan-T cell-associated antigen
(50,000mol.wt)
Coulter Clone Stashenko et al. (1980)
Coulter Clone
J. Wiels
H. Stein
M. Rowe
M. Rowe
H. Stein
Ortho Diagnostics
Ritz et al. (1980)
Wiels et al. (1981)
Stein et al. (1983)
Rowe et al. (1982)
Rowe et al. (1982)
Schwab et al. (1982)
Verbi et al. (1982)
Results
Histopathology ofthe tumour
Paraffin sections showed a diffuse non-Hodgkin's
lymphoma composed of cells with scanty
pyroninophilic cytoplasm and small non-cleaved
nuclei approximating in size to those of adjacent
histiocytes. Each nucleus contained two or more
prominent nucleoli and had coarsely clumped
chromatin. The mitotic rate was high and there was
a conspicuous starry-sky pattern associated with the
presence of many macrophages. In these respects
the histological picture resembled that of endemic
BL - although closer examination revealed some
subtle differences. Thus the tumour cells showed
more nuclear pleomorphism than is typical of
endemic tumours and cytoplasmic lipid vacuoles,
associated with endemic BL cells, were not seen by
electronmicroscopy. The lymphoma was classified
as Malignant Lymphoma, Small Noncleaved Type
according to the Working Formulation of non-
Hodgkin's Lymphomas (1982) or Undifferentiated
Lymphoma according to the classification proposed
by Rappaport (1966) (Figure 1).
Although the biopsy was small it contained
intestinal smooth muscle on its outer aspect
indicating that the lymphoma arose in the
gastrointestinal tract.
Establishment oflymphoma-derived cell line
(DH-BL) and ofEB virus-transformed
lymphoblastoid cell line (DH-LCL)
In the case of the cultured biopsy cells, after a
month of remaining apparently dormant on the
human fibroblast feeder layer the lymphoma cells
then began to proliferate and were subcultured into
plastic tissue culture flasks. The appearance of the
Figure 1 Histopathology of tumour showing
lymphoma cells with scanty cytoplasm and small non-
cleaved nuclei with prominent nucleoli. Many mitotic
figures are present (arrows). One pm plastic section.
H&E (x 625).
line was that of small cells with a slightly irregular
outline, growing mainly as a single cell suspension
but with some small loose clumps apparent even in
the first few passages; clumping became slightly
more pronounced after 6 months of continuous
culture (Figure 2a).
EB virus-infected cultures of peripheral blood
mononuclear cells gave rise to tight clumps of
larger lymphoblastoid cells which could be
subcultured within two weeks of infection to
establish the LCL (Figure 2b).
Characterisation ofDH biopsy cells, DH-BL and
DH-LCL
As shown in Table II both the tumour biopsy cells
B1
J5
38.13
Ki-24
MHM6
AC2
Ki-1
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Figure 2 (a) Appearance in tissue culture of cell line
derived from DH tumour cells - DH-BL - showing
cells growing as single cells and small loose clumps. (b)
Appearance in tissue culture of DH EB virus-
transformed lymphoblastoid cell line - DH-LCL -
showing cells growing in large tight clumps. Phase
contrast photomicrographs.
and the tumour derived cell line, DH-BL, were
EBNA negative and displayed the same monotypic
cxA pattern of surface immunoglobulin expression.
The tumour cell line also displayed the t(8: 14)
(q24q32) translocation (Figure 3) which is
characteristic of BL (Zech et al., 1976). In contrast
DH-LCL was EBNA positive, polyclonal for both
surface and cytoplasmic immunoglobulin and
displayed a normal diploid karyotype.
These same cell populations were also examined
for expression of B cell-associated markers as
defined by the monoclonal antibodies listed in
Table I. The results of repeated tests are
summarised in Table III. The biopsy cell
population was found to consist of 20% infiltrating
T cells as identified with binding to the antibody
OKTII which recognises a pan T cell antigen. The
percentages of fluorescent positive biopsy cells in
Table III were therefore corrected to account only
for the B cell fraction identified by binding to thc
pan B cell antigen (recognised by the antibody BI).
As expected, the cell populations from both DH-BL
and DH-LCL were exclusively B cells as they gave
100% binding with the antibody Bk. Both the
tumour biopsy and the derived DH-BL cell line
expressed two markers - the common acute
lymphoblastic leukaemia antigen cALLA, defined
by J5 staining, and the BL-associated antigen BLA,
defined by 38.13 staining. These two markers have
also been consistently found on all EB virus-
positive BL cell lines studied in early passage
(Rowe et al., 1985). In addition the DH-BL cell line
even when tested in early passage expressed the Ki-
24 antigen on a minority of the cells but did not
stain for any of the other 'Iymphoblastoid' antigens
defined by the antibodies MHM6, AC2 and Ki-I
(see below). DH-BL proved to be essentially stable
on continued passaged (from observations over a
period of six months) and was clearly
distinguishable from that of DH-LCL. The latter
cell line selectively bound Ki-24, MHM6, AC2 and
Ki-I antibodies exactly as described for all other
LCLs thus analysed (Rowe et al., 1985).
Discussion
The present case report concerns an abdominal
lymphoma in an English child which on clinical,
histopathological and cytogenetic grounds clearly
satisfies the criteria for 'sporadic BL' as employed
by other groups (Levine et al., 1982; Philip et al.,
1982). In particular, many features of the
histopathology resembled those seen with the
endemic disease and the tumour showed a t(8:14)
chromosomal translocation, the commonest of three
specific translocations consistently observed in
association with BL (Berger & Bernheim, 1985).
Like most sporadic BLs in Western Europe (Philip,
Table II Characteristics of DH biopsy, DH-BL and DH-LCL cells.
Cells Cytoplasmic Ig Surface Ig EBNA Karyotype
DH Biopsy NTa Monoclonal Negative NT
aA
Negative Monoclonal
a l
Polyclonal Polyclonal
Negative
Positive
46,XY, t(8: 14)(q24q32)
46,XY
'NT - not tested.
DH-BL
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Figure 3 Karyotype of metaphase chromosomes obtained from DH-BL cell line showing 8q- (small arrow)
and 14q+ (large arrow).
Table III Comparison ofmonoclonal antibody binding of DH biopsy, DH-BL and DH-LCL.
Monoclonal antibody binding'
In vitro growth
Cells pattern BJ J5 38.13 Ki-24 MHM6 AC2 Ki-J
DH biopsyb 100 60 95 0 0 0 0
+++ + +++
DH-BL Single cells and 100 78 90 25 0 0 0
small clumps + + + + + + + + +
DH-LCL Large clumps 100 0 0 74 79 80 56
+++ ~~++ ++ +++ ++
aAntibody binding was expressed as the percentage of fluorescent positive cells with an indication of the
relative intensity of the staining. + + + =bright; + + =moderate; + =weak. bBiopsy results were expressed as
the percentage of the B cell population binding the monoclonal antibodies (see text).
1985), this tumour was EB virus-negative and
indeed arose in a child whose serological status
strongly suggested no previous EB virus infection.
The tumour was somewhat unusual, although not
unique amongst cases of sporadic BL (Rowe et al.,
1985) in expressing surface immunoglobulin of class
a rather than class M.
One of the key issues in questioning the
relationship between endemic and sporadic BL is
the identity of the target cell involved in each case.
Previous work has established a panel of
monoclonal antibodies, against B cell-associated
surface antigens, which has proved particularly
useful in defining the various surface phenotypes390 S. FINERTY et al.
displayed by BL cells in culture (Rowe et al., 1985).
These antibodies have recently been used to
characterise endemic BL biopsy cells and their
derived cell lines (Rooney et al., 1986) and the
present report represents the first extension of this
approach to a case of sporadic BL. The results are
interesting in that the cell surface phenotype of the
DH-BL biopsy (Table III) was indistinguishable
from that shown by all biopsies of EB virus-
positive endemic BLs so far examined (Rooney et
al., 1986).
Related work with EB virus-positive BL has
revealed a tendency for many of the derived cell
lines to progress towards a more 'Iymphoblastoid'
phenotype with continued passage in vitro, without
loss of the cytogenetic markers indicative of
malignant origin (Rowe et al., 1985; Rooney et al.,
1986).
The present results with an EB virus-negative BL
cell line are contrary to this general pattern, since
continual culture of the DH-BL line was only
associated with acquisition of a weak reactivity with
the antibody Ki-24 but no further progression
towards the 'lymphoblastoid' phenotype. One
possibility is that the more dramatic examples of
phenotypic progression in vitro represent the
influence of a resident EB virus genome upon an
otherwise stable BL cell phenotype. This view is
indeed supported by the recent observation that
several other established EB virus-negative BL cell
lines show the same phenotype as described here
for DH-BL cells (Rowe et al., 1986).
The overall inference from these studies is that,
despite minor differences in histopathological
appearance between the DH tumour and a typical
case of endemic BL, the tumour cell surface
phenotypes in vivo were indistinguishable (at least
by the panel of markers employed). Although much
more work will be required, this certainly raises the
possibility that both the endemic and sporadic
forms of BL are derived from a cALLA-positive
BLA-positive subset of progenitor cells. Such a
normal subset has not yet been unequivocally
defined but it certainly becomes important to
search for such normal cells in lymphoid tissue,
particularly in mucosa-associated lymphoid tissue
where BL is considered to originate (Wright, 1985).
Furthermore it is important to examine the precise
position of such cells within the B cell lineage.
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